Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „administer“
Suchtreffer
Begriffe & Kennungen
Biktarvy · 4.8 · Patients co-infected with hepatitis B In 16 HIV/HBV co-infected adults administered Biktarvy (8 HIV/HBV treatm
Eintrag öffnenBondronat · 4.5 · 18 Aminoglycosides Caution is advised when bisphosphonates are administered with aminoglycosides, since both s
Eintrag öffnenBondronat · 4.5 · Bioavailability was reduced by approximately 75% when Bondronat tablets were administered 2 hours after a stan
Eintrag öffnenBondronat · 4.5 · Caution is advised when bisphosphonates are administered with aminoglycosides, since both substances can lower
Eintrag öffnenBondronat · 4.5 · Caution is advised when bisphosphonates are administered with aminoglycosides, since both substances can lower
Eintrag öffnenBortezomib Accord · 4.8 · Herpes zoster virus reactivation Multiple myeloma Antiviral prophylaxis was administered to 26% of the patient
Eintrag öffnenBortezomib Accord · 4.8 · Herpes zoster virus reactivation Multiple myeloma Antiviral prophylaxis was administered to 26% of the patient
Eintrag öffnenBortezomib Accord · 4.8 · Mantle cell lymphoma Antiviral prophylaxis was administered to 137 of 240 patients (57%) in the BzR-CAP arm. T
Eintrag öffnenBortezomib Accord · 4.8 · Mantle cell lymphoma Antiviral prophylaxis was administered to 137 of 240 patients (57%) in the BzR-CAP arm. T
Eintrag öffnenBortezomib Accord · 4.8 · Mantle cell lymphoma In study LYM-3002 in which bortezomib was administered with rituximab, cyclophosphamide,
Eintrag öffnenBortezomib Accord · 4.8 · Mantle cell lymphoma In study LYM-3002 in which bortezomib was administered with rituximab, cyclophosphamide,
Eintrag öffnenBortezomib Accord · 4.8 · Notable differences in the safety profile of bortezomib administered subcutaneously versus intravenously as si
Eintrag öffnenBortezomib Accord · 4.8 · Notable differences in the safety profile of bortezomib administered subcutaneously versus intravenously as si
Eintrag öffnenBortezomib Accord · 4.8 · Peripheral neuropathy in combination regimens Multiple myeloma In studies in which bortezomib was administered
Eintrag öffnenBortezomib Accord · 4.8 · Peripheral neuropathy in combination regimens Multiple myeloma In studies in which bortezomib was administered
Eintrag öffnenBortezomib Sun · 4.8 · Mantle cell lymphoma Antiviral prophylaxis was administered to 137 of 240 patients (57%) in the BzmbR-CAP arm.
Eintrag öffnenBortezomib Sun · 4.8 · Mantle cell lymphoma In study LYM-3002 in which bortezomib was administered with rituximab, cyclophosphamide,
Eintrag öffnenBortezomib Sun · 4.8 · Notable differences in the safety profile of bortezomib administered subcutaneously versus intravenously as si
Eintrag öffnenBortezomib Sun · 4.8 · Peripheral neuropathy in combination regimens Multiple myeloma In trials in which bortezomib was administered
Eintrag öffnenBosulif · 4.5 · Based on the large reduction in bosutinib exposure that occurred when bosutinib was co-administered with rifam
Eintrag öffnen